Skip to content
Home/Companies/Healthcare / Ophthalmology/Horus Pharma
Horus Pharma

Horus Pharma

Healthcare / Ophthalmology·France·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Horus Pharma?

Horus Pharma is currently owned by Eurazeo through Nov Sante Actions Non Cotees (2020 vintage), since 2022.

Hand-verified · updated 2026-04-21

Eurazeo
Investor
Eurazeo
Nov Sante Actions Non Cotees · 2020 · Healthcare

Key facts

HQFrance
SectorHealthcare / Ophthalmology
Websitewww.horus-pharma.com

More from Nov Sante Actions Non Cotees

Other portfolio companies in the same fund.

Proteor
Proteor
Active
MedTechFrance· 2025
Imapole
Imapole
Active
MedTechFrance· 2023
Kinvent
Kinvent
Active
MedTechFrance· 2023
Oncodesign
Oncodesign
Active
BiotechFrance· 2022
Groupe PSIH
Groupe PSIH
Active
HealthTechFrance· 2021
Novair
Novair
Active
MedTechFrance· 2021

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Horus Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Horus Pharma?

0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Horus Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue